UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:ACIN1-NUTM1 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: ACIN1-NUTM1 | FusionPDB ID: 1310 | FusionGDB2.0 ID: 1310 | Hgene | Tgene | Gene symbol | ACIN1 | NUTM1 | Gene ID | 22985 | 256646 |
Gene name | apoptotic chromatin condensation inducer 1 | NUT midline carcinoma family member 1 | |
Synonyms | ACINUS|ACN|fSAP152 | C15orf55|FAM22H|NUT | |
Cytomap | 14q11.2 | 15q14 | |
Type of gene | protein-coding | protein-coding | |
Description | apoptotic chromatin condensation inducer in the nucleusfunctional spliceosome-associated protein 152 | NUT family member 1nuclear protein in testis | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9UKV3 | Q86Y26 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000262710, ENST00000457657, ENST00000555053, ENST00000605057, ENST00000338631, ENST00000357481, ENST00000397341, ENST00000555352, ENST00000557515, | ENST00000333756, ENST00000438749, ENST00000537011, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 12 X 11 X 4=528 | 6 X 5 X 4=120 |
# samples | 13 | 5 | |
** MAII score | log2(13/528*10)=-2.02202630633 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/120*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ACIN1 [Title/Abstract] AND NUTM1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | |||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ACIN1 | GO:0030263 | apoptotic chromosome condensation | 10490026 |
Fusion gene breakpoints across ACIN1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across NUTM1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerKB3 | . | . | ACIN1 | chr14 | 23559191 | - | NUTM1 | chr | 34640170 | + |
ChimerKB3 | . | . | ACIN1 | chr14 | 23559731 | - | NUTM1 | chr | 34640168 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000605057 | ACIN1 | chr14 | 23559191 | - | ENST00000537011 | NUTM1 | chr | 34640170 | + | 1470 | 477 | 41 | 1468 | 476 |
ENST00000605057 | ACIN1 | chr14 | 23559191 | - | ENST00000438749 | NUTM1 | chr | 34640170 | + | 1470 | 477 | 41 | 1468 | 476 |
ENST00000605057 | ACIN1 | chr14 | 23559191 | - | ENST00000333756 | NUTM1 | chr | 34640170 | + | 1470 | 477 | 41 | 1468 | 476 |
ENST00000262710 | ACIN1 | chr14 | 23559191 | - | ENST00000537011 | NUTM1 | chr | 34640170 | + | 1931 | 938 | 319 | 1929 | 537 |
ENST00000262710 | ACIN1 | chr14 | 23559191 | - | ENST00000438749 | NUTM1 | chr | 34640170 | + | 1931 | 938 | 319 | 1929 | 537 |
ENST00000262710 | ACIN1 | chr14 | 23559191 | - | ENST00000333756 | NUTM1 | chr | 34640170 | + | 1931 | 938 | 319 | 1929 | 537 |
ENST00000555053 | ACIN1 | chr14 | 23559191 | - | ENST00000537011 | NUTM1 | chr | 34640170 | + | 1700 | 707 | 88 | 1698 | 537 |
ENST00000555053 | ACIN1 | chr14 | 23559191 | - | ENST00000438749 | NUTM1 | chr | 34640170 | + | 1700 | 707 | 88 | 1698 | 537 |
ENST00000555053 | ACIN1 | chr14 | 23559191 | - | ENST00000333756 | NUTM1 | chr | 34640170 | + | 1700 | 707 | 88 | 1698 | 537 |
ENST00000605057 | ACIN1 | chr14 | 23559731 | - | ENST00000537011 | NUTM1 | chr | 34640168 | + | 1350 | 357 | 41 | 1348 | 436 |
ENST00000605057 | ACIN1 | chr14 | 23559731 | - | ENST00000438749 | NUTM1 | chr | 34640168 | + | 1350 | 357 | 41 | 1348 | 436 |
ENST00000605057 | ACIN1 | chr14 | 23559731 | - | ENST00000333756 | NUTM1 | chr | 34640168 | + | 1350 | 357 | 41 | 1348 | 436 |
ENST00000457657 | ACIN1 | chr14 | 23559731 | - | ENST00000537011 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000457657 | ACIN1 | chr14 | 23559731 | - | ENST00000438749 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000457657 | ACIN1 | chr14 | 23559731 | - | ENST00000333756 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000262710 | ACIN1 | chr14 | 23559731 | - | ENST00000537011 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000262710 | ACIN1 | chr14 | 23559731 | - | ENST00000438749 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000262710 | ACIN1 | chr14 | 23559731 | - | ENST00000333756 | NUTM1 | chr | 34640168 | + | 1811 | 818 | 319 | 1809 | 497 |
ENST00000555053 | ACIN1 | chr14 | 23559731 | - | ENST00000537011 | NUTM1 | chr | 34640168 | + | 1580 | 587 | 88 | 1578 | 497 |
ENST00000555053 | ACIN1 | chr14 | 23559731 | - | ENST00000438749 | NUTM1 | chr | 34640168 | + | 1580 | 587 | 88 | 1578 | 497 |
ENST00000555053 | ACIN1 | chr14 | 23559731 | - | ENST00000333756 | NUTM1 | chr | 34640168 | + | 1580 | 587 | 88 | 1578 | 497 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >1310_1310_1_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000262710_NUTM1_chr_34640170_ENST00000333756_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_2_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000262710_NUTM1_chr_34640170_ENST00000438749_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_3_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000262710_NUTM1_chr_34640170_ENST00000537011_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_4_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000555053_NUTM1_chr_34640170_ENST00000333756_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_5_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000555053_NUTM1_chr_34640170_ENST00000438749_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_6_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000555053_NUTM1_chr_34640170_ENST00000537011_length(amino acids)=537AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYT CHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNS SEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG -------------------------------------------------------------- >1310_1310_7_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000605057_NUTM1_chr_34640170_ENST00000333756_length(amino acids)=476AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDK SSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEV GELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRIC TRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVR -------------------------------------------------------------- >1310_1310_8_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000605057_NUTM1_chr_34640170_ENST00000438749_length(amino acids)=476AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDK SSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEV GELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRIC TRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVR -------------------------------------------------------------- >1310_1310_9_ACIN1-NUTM1_ACIN1_chr14_23559191_ENST00000605057_NUTM1_chr_34640170_ENST00000537011_length(amino acids)=476AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELELSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDK SSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEV GELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRIC TRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVR -------------------------------------------------------------- >1310_1310_10_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000262710_NUTM1_chr_34640168_ENST00000333756_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_11_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000262710_NUTM1_chr_34640168_ENST00000438749_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_12_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000262710_NUTM1_chr_34640168_ENST00000537011_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_13_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000457657_NUTM1_chr_34640168_ENST00000333756_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_14_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000457657_NUTM1_chr_34640168_ENST00000438749_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_15_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000457657_NUTM1_chr_34640168_ENST00000537011_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_16_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000555053_NUTM1_chr_34640168_ENST00000333756_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_17_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000555053_NUTM1_chr_34640168_ENST00000438749_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_18_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000555053_NUTM1_chr_34640168_ENST00000537011_length(amino acids)=497AA_BP= MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEAIETQSSSSEEIVP SPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRN KKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE -------------------------------------------------------------- >1310_1310_19_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000605057_NUTM1_chr_34640168_ENST00000333756_length(amino acids)=436AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEAIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINK VTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDL WDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAN -------------------------------------------------------------- >1310_1310_20_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000605057_NUTM1_chr_34640168_ENST00000438749_length(amino acids)=436AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEAIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINK VTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDL WDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAN -------------------------------------------------------------- >1310_1310_21_ACIN1-NUTM1_ACIN1_chr14_23559731_ENST00000605057_NUTM1_chr_34640168_ENST00000537011_length(amino acids)=436AA_BP= MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEAIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINK VTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDL WDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAN -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:/chr:) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ACIN1 | NUTM1 |
FUNCTION: Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets; ACIN1 confers RNA-binding to the complex. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Induces apoptotic chromatin condensation after activation by CASP3. Regulates cyclin A1, but not cyclin A2, expression in leukemia cells. {ECO:0000269|PubMed:10490026, ECO:0000269|PubMed:12665594, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:22203037, ECO:0000269|PubMed:22388736}. | FUNCTION: Plays a role in the regulation of proliferation. Regulates TERT expression by modulating SP1 binding to TERT promoter binding sites. {ECO:0000269|PubMed:30447097}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Protein Structures |
PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file (200) >>>200.pdbFusion protein BP residue: CIF file (200) >>>200.cif | ACIN1 | chr14 | 23559731 | - | NUTM1 | chr | 34640168 | + | MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALML ENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREARE AAELEAIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSA CEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMS KESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQ LGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTI ADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGP LTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEP | 436 |
3D view using mol* of 200 (AA BP:) | ||||||||||
PDB file (255) >>>255.pdbFusion protein BP residue: CIF file (255) >>>255.cif | ACIN1 | chr14 | 23559191 | - | NUTM1 | chr | 34640170 | + | MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALML ENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREARE AAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELELSRHSPTIETQ SSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRR SIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNK KKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSS EQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAA CLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAN QLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVR | 476 |
3D view using mol* of 255 (AA BP:) | ||||||||||
PDB file (293) >>>293.pdbFusion protein BP residue: CIF file (293) >>>293.cif | ACIN1 | chr14 | 23559731 | - | NUTM1 | chr | 34640168 | + | MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPE AVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSA LVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQEL LRQRLEREAREAAELEAIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQD KSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYC RLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRK AHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFA KQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLN RTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLE | 497 |
3D view using mol* of 293 (AA BP:) | ||||||||||
PDB file (368) >>>368.pdbFusion protein BP residue: CIF file (368) >>>368.cif | ACIN1 | chr14 | 23559191 | - | NUTM1 | chr | 34640170 | + | MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPE AVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSA LVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQEL LRQRLEREAREAAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELE LSRHSPTIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVS ACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGM SKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALC QLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLT IADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFG PLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQE | 537 |
3D view using mol* of 368 (AA BP:) | ||||||||||
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
ACIN1_pLDDT.png |
NUTM1_pLDDT.png |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
ACIN1_NUTM1_200.png |
ACIN1_NUTM1_255.png |
ACIN1_NUTM1_293.png |
ACIN1_NUTM1_368.png |
Top |
Potential Active Site Information |
The potential binding sites of these fusion proteins were identified using SiteMap, a module of the Schrodinger suite. |
Fusion AA seq ID in FusionPDB | Site score | Size | D score | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
200 | 1.119 | 175 | 1.148 | 405.083 | 0.417 | 0.835 | 1.107 | 1.44 | 0.899 | 1.602 | 0.722 | Chain A: 82,83,86,89,90,92,93,96,245,265,266,271,2 74,275,277,278,280,281,312,315,316,318,319,322,332 ,333,344,347,348,349,350,351,354,436 |
200 | 1.149 | 101 | 1.229 | 216.433 | 0.502 | 0.777 | 1.077 | 2.495 | 0.543 | 4.592 | 1.483 | Chain A: 244,245,246,274,277,278,280,281,284,312,3 15,316,318,319,322,332,333,334,347,348,351,355 |
255 | 1.143 | 263 | 1.228 | 646.212 | 0.446 | 0.762 | 1.019 | 2.568 | 0.519 | 4.948 | 1.159 | Chain A: 73,78,79,82,83,90,93,94,97,285,305,306,30 8,311,314,317,318,319,321,322,323,324,325,326,327, 330,335,340,343,344,347,348,349,350,351,352,353,35 5,356,358,359,362,371,372,373,384,387,388,389,391, 395 |
293 | 0.99 | 169 | 1.012 | 477.113 | 0.525 | 0.68 | 0.904 | 0.49 | 1.033 | 0.475 | 1.057 | Chain A: 3,4,5,6,7,8,41,42,43,44,45,46,47,48,329,3 32,333,336,337,340,341,343,344,369 |
368 | 0.9112 | 1067 | 1.0225 | 526.162 | 0.7164 | 0.4101 | 0.3648 | 0.2725 | 0.5015 | 0.5433 | 0.9119 | Chain A: 1,2,3,4,5,6,7,8,9,10,11,12,355,357,358,35 9,366,367,370,371,372,373,374,375,376,377,378,380, 381,383,384,387,388,391,396,397,401,402,403,404,40 5,406,408,409,410,412,413,414,416,417,420,433,435, 437,445,448,449,450,451,452,456,485,486,487,488,48 9,490,532,535,536,537 |
Top |
Potentially Interacting Small Molecules through Virtual Screening |
The FDA-approved small molecule library molecules were subjected to virtual screening using the Glide. |
Fusion AA seq ID in FusionPDB | ZINC ID | DrugBank ID | Drug name | Docking score | Glide gscore |
200 | ZINC000006467621 | DB11115 | Ensulizole | -8.53108 | -8.94198 |
200 | ZINC000001530886 | DB00966 | Telmisartan | -6.91402 | -8.78602 |
200 | ZINC000003775644 | DB01123 | Proflavine | -8.38021 | -8.41101 |
200 | ZINC000012414057 | DB08167 | Methylthioninium | -8.34226 | -8.34526 |
200 | ZINC000000643153 | DB01026 | Ketoconazole | -8.00171 | -8.32641 |
200 | ZINC000003784182 | DB00210 | Adapalene | -8.15412 | -8.15462 |
200 | ZINC000003871541 | DB00261 | Anagrelide | -7.96023 | -7.96023 |
200 | ZINC000019632614 | DB00317 | Gefitinib | -7.54063 | -7.95563 |
200 | ZINC000000020243 | DB00861 | Diflunisal | -7.93043 | -7.93043 |
200 | ZINC000007997897 | DB00735 | Naftifine | -7.78599 | -7.86549 |
200 | Netarsudil | DB00735 | -5.41883 | -7.78113 | |
200 | ZINC000000020221 | DB00461 | Nabumetone | -7.77018 | -7.77018 |
200 | ZINC000005733652 | DB11259 | Diosmetin | -7.67373 | -7.70973 |
200 | ZINC000000403010 | DB00598 | Labetalol | -7.64109 | -7.66869 |
200 | ZINC000003873371 | DB06820 | Sulconazole | -7.28918 | -7.62058 |
200 | ZINC000000018635 | DB00998 | Frovatriptan | -7.61229 | -7.61279 |
200 | ZINC000004676424 | DB00213 | Pantoprazole | -5.50102 | -7.58682 |
200 | ZINC000002568036 | DB01219 | Dantrolene | -7.49747 | -7.56987 |
200 | ZINC000252679615 | DB01219 | Dantrolene | -7.49747 | -7.56987 |
200 | ZINC000000896740 | DB01110 | Miconazole | -7.35821 | -7.56541 |
Top |
Drug information from DrugBank of the top 20 interacting small molecules. |
ZINC ID | DrugBank ID | Drug name | Drug type | SMILES | Drug group |
ZINC000006467621 | DB11115 | Ensulizole | Small molecule | OS(=O)(=O)C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1 | Approved |
ZINC000001530886 | DB00966 | Telmisartan | Small molecule | CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O | Approved|Investigational |
ZINC000003775644 | DB01123 | Proflavine | Small molecule | NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1 | Approved |
ZINC000012414057 | DB08167 | Methylthioninium | Small molecule | CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C | Experimental|Investigational |
ZINC000000643153 | DB01026 | Ketoconazole | Small molecule | CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1 | Approved|Investigational |
ZINC000003784182 | DB00210 | Adapalene | Small molecule | COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2 | Approved |
ZINC000003871541 | DB00261 | Anagrelide | Small molecule | ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl | Approved |
ZINC000019632614 | DB00317 | Gefitinib | Small molecule | COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1 | Approved|Investigational |
ZINC000000020243 | DB00861 | Diflunisal | Small molecule | OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1 | Approved|Investigational |
ZINC000007997897 | DB00735 | Naftifine | Small molecule | CN(CC=CC1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12 | Approved |
ZINC000000020221 | DB00461 | Nabumetone | Small molecule | COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2 | Approved |
ZINC000005733652 | DB11259 | Diosmetin | Small molecule | COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O | Experimental |
ZINC000000018635 | DB00998 | Frovatriptan | Small molecule | CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O | Approved|Investigational |
ZINC000004676424 | DB00213 | Pantoprazole | Small molecule | COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1 | Approved |
Top |
Biochemical Features of Small Molecules |
ADME (Absorption, Distribution, Metabolism, and Excretion) of drugs using QikProp(v3.9) |
ZINC ID | mol_MW | dipole | SASA | FOSA | FISA | PISA | WPSA | volume | donorHB | accptHB | IP | Human Oral Absorption | Percent Human Oral Absorption | Rule Of Five | Rule Of Three |
ZINC000006467621 | 274.294 | 9.514 | 495.179 | 0 | 165.642 | 327.077 | 2.46 | 816.857 | 2 | 5.5 | 9.09 | 3 | 70.241 | 0 | 0 |
ZINC000006467621 | 274.294 | 5.937 | 496.167 | 0 | 165.586 | 328.124 | 2.456 | 817.805 | 2 | 5.5 | 9.121 | 3 | 70.288 | 0 | 0 |
ZINC000006467621 | 274.294 | 9.57 | 496.894 | 0 | 166.022 | 328.377 | 2.495 | 819.646 | 2 | 5.5 | 8.954 | 3 | 70.264 | 0 | 0 |
ZINC000001530886 | 514.626 | 7.48 | 850.985 | 294.329 | 111.948 | 444.709 | 0 | 1601.819 | 1 | 5 | 8.498 | 1 | 86.979 | 2 | 1 |
ZINC000001530886 | 514.626 | 3.392 | 898.781 | 323.212 | 100.491 | 475.078 | 0 | 1648.918 | 1 | 5 | 8.623 | 1 | 91.314 | 2 | 1 |
ZINC000001530886 | 514.626 | 6.83 | 830.587 | 285.837 | 116.397 | 428.353 | 0 | 1580.24 | 1 | 5 | 8.44 | 1 | 85.144 | 2 | 1 |
ZINC000001530886 | 514.626 | 8.764 | 825.335 | 324.054 | 51.458 | 449.823 | 0 | 1592.388 | 1 | 5 | 8.537 | 1 | 100 | 2 | 1 |
ZINC000003775644 | 209.25 | 0.181 | 433.081 | 0 | 137.936 | 295.144 | 0 | 706.541 | 3 | 3 | 7.603 | 3 | 83.637 | 0 | 0 |
ZINC000003775644 | 209.25 | 0.371 | 432.112 | 0 | 138.151 | 293.961 | 0 | 705.014 | 3 | 3 | 7.627 | 3 | 83.535 | 0 | 0 |
ZINC000000643153 | 531.438 | 4.384 | 839.249 | 315.215 | 79.661 | 325.769 | 118.605 | 1545.907 | 0 | 8.25 | 8.127 | 3 | 92.682 | 1 | 0 |
ZINC000000643153 | 531.438 | 6.93 | 833.589 | 316.347 | 79.801 | 318.588 | 118.853 | 1539.922 | 0 | 8.25 | 8.129 | 3 | 92.72 | 1 | 0 |
ZINC000000643153 | 531.438 | 7.908 | 857.901 | 337.4 | 75.081 | 326.963 | 118.457 | 1564.786 | 0 | 8.25 | 9.251 | 3 | 93.859 | 1 | 0 |
ZINC000000643153 | 531.438 | 7.932 | 859.065 | 337.499 | 75.339 | 327.516 | 118.711 | 1562.192 | 0 | 8.25 | 9.243 | 3 | 93.791 | 1 | 0 |
ZINC000003784182 | 412.527 | 4.577 | 711.883 | 341.679 | 105.692 | 264.513 | 0 | 1306.999 | 1 | 2.75 | 8.652 | 1 | 94.648 | 1 | 1 |
ZINC000003871541 | 256.091 | 5.713 | 431.016 | 83.331 | 115.582 | 113.587 | 118.517 | 708.292 | 1 | 4.5 | 9.009 | 3 | 88.694 | 0 | 0 |
ZINC000019632614 | 446.908 | 5.605 | 766.017 | 373.784 | 38.968 | 243.44 | 109.824 | 1351.73 | 1 | 7.7 | 8.493 | 3 | 100 | 0 | 0 |
ZINC000019632614 | 446.908 | 5.389 | 803.125 | 411.613 | 39.025 | 242.679 | 109.806 | 1392.008 | 1 | 7.7 | 8.484 | 3 | 100 | 0 | 1 |
ZINC000000020243 | 250.201 | 8.261 | 459.081 | 0 | 144.436 | 231.005 | 83.64 | 751.879 | 1 | 1.75 | 9.879 | 3 | 86.601 | 0 | 0 |
ZINC000007997897 | 287.404 | 0.789 | 607.9 | 141.903 | 0.103 | 465.895 | 0 | 1056.595 | 0 | 2 | 8.523 | 3 | 100 | 1 | 0 |
ZINC000007997897 | 287.404 | 0.718 | 598.565 | 138.957 | 0 | 459.608 | 0 | 1048.049 | 0 | 2 | 8.531 | 3 | 100 | 1 | 0 |
ZINC000007997897 | 287.404 | 0.791 | 521.98 | 157.971 | 2.38 | 361.628 | 0 | 973.251 | 0 | 2 | 8.498 | 3 | 100 | 0 | 0 |
ZINC000000020221 | 228.29 | 3.885 | 504.783 | 246.14 | 47.874 | 210.768 | 0 | 841.575 | 0 | 2.75 | 8.539 | 3 | 100 | 0 | 0 |
ZINC000005733652 | 300.267 | 4.88 | 528.855 | 93.31 | 204.424 | 231.12 | 0 | 896.841 | 2 | 4.5 | 8.9 | 3 | 73.982 | 0 | 0 |
ZINC000005733652 | 300.267 | 6.652 | 527.118 | 93.294 | 202.511 | 231.313 | 0 | 894.005 | 2 | 4.5 | 8.908 | 3 | 74.287 | 0 | 0 |
ZINC000000403010 | 328.41 | 5.633 | 665.048 | 169.772 | 199.786 | 295.49 | 0 | 1141.271 | 4 | 5.45 | 9.068 | 2 | 70.572 | 0 | 0 |
ZINC000000403010 | 328.41 | 8.153 | 662.671 | 168.348 | 200.011 | 294.312 | 0 | 1140.633 | 4 | 5.45 | 9.267 | 2 | 70.521 | 0 | 0 |
ZINC000003873371 | 397.749 | 4.24 | 592.998 | 55.479 | 28.414 | 315.842 | 193.264 | 1087.327 | 0 | 2.5 | 9.366 | 1 | 100 | 1 | 1 |
ZINC000003873371 | 397.749 | 5.797 | 597.39 | 71.098 | 30.348 | 301.939 | 194.006 | 1088.013 | 0 | 2.5 | 9.324 | 1 | 100 | 1 | 1 |
ZINC000000018635 | 243.308 | 7.2 | 492.762 | 217.467 | 154.534 | 120.761 | 0 | 833.223 | 4 | 4 | 8.296 | 3 | 66.41 | 0 | 0 |
ZINC000004676424 | 383.369 | 8.251 | 592.117 | 212.645 | 84.97 | 180.573 | 113.929 | 1072.52 | 1 | 8 | 9.002 | 3 | 74.595 | 0 | 0 |
ZINC000004676424 | 383.369 | 7.215 | 561.053 | 186.64 | 84.216 | 176.622 | 113.575 | 1038.795 | 1 | 8 | 9.168 | 3 | 73.698 | 0 | 0 |
ZINC000004676424 | 383.369 | 4.727 | 588.455 | 213.533 | 85.064 | 183.201 | 106.656 | 1066.712 | 1 | 8 | 8.895 | 3 | 74.241 | 0 | 0 |
ZINC000004676424 | 383.369 | 5.371 | 591.248 | 214.444 | 86.708 | 182.582 | 107.515 | 1072.188 | 1 | 8 | 8.894 | 3 | 74.097 | 0 | 0 |
ZINC000002568036 | 314.257 | 3.867 | 548.758 | 54.323 | 243.185 | 251.25 | 0 | 924.46 | 1 | 5 | 9.205 | 3 | 67.058 | 0 | 0 |
ZINC000002568036 | 314.257 | 4.186 | 547.3 | 54.729 | 241.127 | 251.444 | 0 | 922.097 | 1 | 5 | 9.191 | 3 | 67.408 | 0 | 0 |
ZINC000252679615 | 314.257 | 3.867 | 548.758 | 54.323 | 243.185 | 251.25 | 0 | 924.46 | 1 | 5 | 9.205 | 3 | 67.058 | 0 | 0 |
ZINC000252679615 | 314.257 | 2.557 | 527.996 | 64.383 | 238.233 | 225.38 | 0 | 905.494 | 1 | 5 | 9.686 | 3 | 67.506 | 0 | 0 |
ZINC000252679615 | 314.257 | 4.186 | 547.3 | 54.729 | 241.127 | 251.444 | 0 | 922.097 | 1 | 5 | 9.191 | 3 | 67.408 | 0 | 0 |
ZINC000252679615 | 314.257 | 2.845 | 525.884 | 65.15 | 235.939 | 224.795 | 0 | 902.055 | 1 | 5 | 9.671 | 3 | 67.875 | 0 | 0 |
ZINC000000896740 | 416.133 | 6.333 | 627.144 | 57.14 | 30.582 | 311.804 | 227.617 | 1129.93 | 0 | 3.7 | 9.196 | 3 | 100 | 1 | 1 |
ZINC000000896740 | 416.133 | 6.395 | 627.238 | 57.065 | 31.054 | 311.648 | 227.471 | 1127.917 | 0 | 3.7 | 9.189 | 3 | 100 | 1 | 1 |
Top |
Drug Toxicity Information |
Toxicity information of individual drugs using eToxPred |
ZINC ID | Smile | Surface Accessibility | Toxicity |
ZINC000006467621 | O=S(=O)(O)c1ccc2[nH]c(-c3ccccc3)nc2c1 | 0.38504104 | 0.405031793 |
ZINC000001530886 | CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1 | 0.217762781 | 0.303280041 |
ZINC000003775644 | Nc1ccc2cc3ccc(N)cc3nc2c1 | 0.346762085 | 0.473171062 |
ZINC000012414057 | CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1 | 0.17581235 | 0.481215426 |
ZINC000000643153 | CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 | 0.087393272 | 0.387082142 |
ZINC000003784182 | COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2 | 0.08640685 | 0.326661019 |
ZINC000003871541 | O=C1CN2Cc3c(ccc(Cl)c3Cl)NC2=N1 | 0.154511471 | 0.436231104 |
ZINC000019632614 | COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1 | 0.262538498 | 0.113127421 |
ZINC000000020243 | O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O | 0.440409373 | 0.371648269 |
ZINC000007997897 | CN(C/C=Cc1ccccc1)Cc1cccc2ccccc12 | 0.394772836 | 0.303491673 |
ZINC000000020221 | COc1ccc2cc(CCC(C)=O)ccc2c1 | 0.488571963 | 0.340637585 |
ZINC000005733652 | COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1O | 0.260199086 | 0.67867566 |
ZINC000000403010 | C[C@@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1 | 0.163888793 | 0.349082082 |
ZINC000003873371 | Clc1ccc(CS[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 | 0.158504654 | 0.345558409 |
ZINC000000018635 | CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1 | 0.15678731 | 0.476568578 |
ZINC000004676424 | COc1ccnc(C[S@@](=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC | 0.114667354 | 0.321842622 |
ZINC000002568036 | O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1 | 0.204070823 | 0.461176527 |
ZINC000252679615 | O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(O)=N1 | 0.149132109 | 0.500589886 |
ZINC000000896740 | Clc1ccc(CO[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 | 0.155145616 | 0.325725199 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
ACIN1 | ABCF3, PAFAH1B2, BANF1, SAP18, SRRM1, tat, RBM39, ELAVL1, SF3A2, SIRT7, HNRNPA1, RNPS1, CUL3, ALYREF, GRK5, BCAS2, SMU1, DHX9, DHX15, DDX17, PRPF6, SF3A1, WIBG, CSGALNACT1, SEPT7, SRP14, RHOT2, BET1, FUT8, DHRS7B, TRMT112, UTP14A, RRP7A, ATP7A, SEPT2, SNAP91, ARMCX3, CAV1, EVPL, S100A9, PRKCA, SMC1A, BOP1, PTCD3, THRAP3, LGMN, NFIA, SUPT16H, RCC1, SNRPGP15, SAFB, SON, RRS1, NDUFAF4, EIF4A3, MAGOH, SRPK2, CSNK2A1, HDAC6, HDAC11, PCBD1, SRPK1, CLK2, rev, WWOX, LGR4, CUL7, OBSL1, SUZ12, EED, RNF2, BMI1, LUZP4, PRPF40A, VTI1B, LUC7L, LUC7L2, SNIP1, EPB41L3, NTRK1, RPL7, RPS13, SLC3A2, SRRM2, SSRP1, SUB1, ZC3H18, IFI16, HIST1H3E, SGTB, Lgals3bp, Rab5c, Esrrb, Ccdc9, SNW1, SENP3, U2AF2, CAMKV, C11orf57, EPB41L2, PIP4K2A, WSB2, KLHL2, PNN, U2AF1, SARNP, TMEM184B, INSL6, ARRB1, ELAVL2, DENND2D, SNRPA1, COX15, DLD, DLST, DNM1L, PDHA1, LMNA, API5, DDX39B, PPIE, GSK3A, IQGAP1, KRAS, PCBP1, TNIP2, CHD3, CHD4, ESR2, EZH2, MYC, CDK9, ACTC1, TPT1, NR2C2, PPP1CC, XRCC6, YAP1, HIST1H4A, SNRNP70, FUS, TAF15, SBF1, HMGB1, BIRC3, STAU1, PLEKHA4, RAD18, PINK1, ENG, LINC01554, CIT, ANLN, CHMP4C, ECT2, KIF14, KIF23, PRC1, MKI67, HNRNPH1, SUMO2, EGFR, NUPR1, CIC, BRD4, Apc2, vpr, CFAP20, ZRANB2, PHRF1, RBBP6, DDX58, UFL1, DDX23, WDR5, NAA40, ZBTB2, SULF2, ARGLU1, HNRNPUL2, NKAP, NFKBIL1, ZC3H11A, SRPK3, RNF151, EPB41L1, SRSF6, SRSF4, PABPC5, SRSF11, C1orf35, TECTB, GOLGA7, SRSF7, MAPKAPK2, CLK3, CUL9, NRP1, TOP3B, CTSL, FURIN, ACE2, E, ORF10, ORF7b, ORF8, BRD2, BRD3, |
NUTM1 | EP300, ALOX5, IFIT2, KPNA2, LMO1, LMO2, PRKAA2, TP53BP2, NEBL, ZNF277, SAMD4A, PSME4, ZMYND10, CCHCR1, LMO3, RIC8A, SH2D4A, HSPBAP1, FAM161A, MORN4, P4HA3, KANSL1, LHX8, AXIN1, SMARCD1, MBD3, TXN2, TTC23, AES, CHCHD3, CDK18, RCOR3, ENKD1, ARHGEF6, PRKAB2, OSTF1, SOGA1, ALS2CR11, CCDC116, SCNM1, CDC20B, PRPF18, METTL17, TBC1D21, LRRC8E, TSGA10IP, PLEKHF2, CCDC185, SAMD4B, GADD45GIP1, KANK2, TEAD4, SH2D1B, GPANK1, AQP1, E7, nsp8, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
ACIN1 | |
NUTM1 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ACIN1-NUTM1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ACIN1-NUTM1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ACIN1 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Tgene | NUTM1 | C1707291 | NUT midline carcinoma | 1 | ORPHANET |